Observational study on hyperthyroidism in children
Official title: A Retrospective and Prospective Observational Study of Hyperthyroidism in Children
Run by Shengjing Hospital · NCT06570967 · Data updated 2026-11-12
This study looks at children with hyperthyroidism to see how they are diagnosed, treated, and what their long-term health outcomes are like.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 29 Days to 14 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Shengjing Hospital Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Status | Recruiting |
| Started | July 18, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | August 27, 2024 |
| Trial ID | NCT06570967 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 14 years or younger with a confirmed diagnosis of hyperthyroidism.
✕Probably not a fit
Patients who have previously received treatment for hyperthyroidism at other hospitals or have certain medical histories may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study conducts both retrospective and prospective assessments of children diagnosed with hyperthyroidism. It aims to gather information on diagnosis, treatment, and long-term outcomes, focusing on clinical characteristics, treatment effects, side effects, and remission rates. The study will analyze predictive factors for treatment efficacy and the risk of adverse reactions related to antithyroid medications. It is a non-interventional study, meaning no new treatments will be administered; rather, existing data will be utilized.
Why it matters
Potential benefit: If successful, this study could enhance understanding of hyperthyroidism management in children, leading to improved treatment strategies.
How similar studies have gone: While this study is observational and builds on existing knowledge, similar studies have previously provided valuable insights into pediatric hyperthyroidism management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≤14 years old 2. Initial diagnosis of hyperthyroidism Exclusion Criteria: 1. Hyperthyroidism had been treated with medication in other hospitals, 2. History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation, 3. Patients with incomplete clinical data
Where it's running
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China Recruiting
Study contacts
- Study coordinator: Shi Tang, Doctor
- Email: ts047827@163.com
- Phone: +8618940259064
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ETHY-001 safety and activity in Thyroid Eye Disease (TED)
This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.
-
Can a smart wristband help guide levothyroxine dosing after total thyroidectomy
This study tests whether nighttime heart rate and rhythm data from a wearable can hint if levothyroxine dose is too high or too low before the usual blood tests.
-
Investigating how hyperthyroidism affects kidney transplant outcomes
This study looks at how changes in thyroid function right after a kidney transplant can affect recovery and overall health for patients.
-
Using Lugol's solution before thyroid surgery for hyperthyroidism
This study is testing if taking Lugol's solution before thyroid surgery can help reduce complications for people with hyperthyroidism.
-
Understanding thyroid function disorders
This study looks at people with thyroid problems, like hyperthyroidism and hypothyroidism, to see how these conditions develop and what factors might be involved.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.